NFE2L2 and cancer: According to a recent pan-cancer whole genome analysis, non-small cell lung cancer has the highest mutation frequency in both KEAP1 and NFE2L2 (ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, 2020).